BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34255590)

  • 1. Safety of hormone replacement therapy in women with a history of cervical adenocarcinoma.
    Richardson A; Watson L; Persic M; Phillips A
    Post Reprod Health; 2021 Sep; 27(3):167-173. PubMed ID: 34255590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix.
    Lacey JV; Brinton LA; Barnes WA; Gravitt PE; Greenberg MD; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Kurman RJ; Hildesheim A
    Gynecol Oncol; 2000 Apr; 77(1):149-54. PubMed ID: 10739704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy and cervical cancer: a systematic review of the literature.
    Vargiu V; Amar ID; Rosati A; Dinoi G; Turco LC; Capozzi VA; Scambia G; Villa P
    Climacteric; 2021 Apr; 24(2):120-127. PubMed ID: 33236658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety of postoperative hormone replacement therapy in epithelial ovarian cancer patients in China.
    Wen Y; Huang H; Huang H; Wu M; Shen K; Pan L
    Climacteric; 2013 Dec; 16(6):673-81. PubMed ID: 23710587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menopause, hormone replacement and gynaecological cancers.
    Hinds L; Price J
    Menopause Int; 2010 Jun; 16(2):89-93. PubMed ID: 20729501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy in women with iatrogenic premature ovarian insufficiency after radiotherapy for cervical cancer: A retrospective cohort and survey study.
    van der Hoef C; Bawuah Dsane L; Schuur N; Louwers YV; Mens JW; Hikary-Bhal N; van Doorn HC
    Maturitas; 2024 Jul; 185():108004. PubMed ID: 38663162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy after treatment for cervical cancer: Are we adhering to standard of care?
    Rauh LA; Pannone AF; Cantrell LA
    Gynecol Oncol; 2017 Dec; 147(3):597-600. PubMed ID: 28923411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical Cancer in Women Aged 35 Years and Younger.
    Pelkofski E; Stine J; Wages NA; Gehrig PA; Kim KH; Cantrell LA
    Clin Ther; 2016 Mar; 38(3):459-66. PubMed ID: 26899314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy and cancer survival: a longitudinal cohort study: protocol paper.
    Ranger TA; Burchardt J; Clift AK; Mei WX; Coupland C; Tan PS; Dixon S; Cardwell CR; Hippisley-Cox J
    BMJ Open; 2021 Aug; 11(8):e046701. PubMed ID: 34341043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone Replacement Therapy in Cancer Survivors - Review of the Literature.
    Deli T; Orosz M; Jakab A
    Pathol Oncol Res; 2020 Jan; 26(1):63-78. PubMed ID: 30617760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen hormone replacement therapy in incidental intracranial meningioma: a growth-rate analysis.
    Dresser L; Yuen CA; Wilmington A; Walker M; Vogel TJ; Merrell RT; Kamson DO
    Sci Rep; 2020 Oct; 10(1):17960. PubMed ID: 33087798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen and combined hormone therapy for women after genital malignancies: a review.
    Levgur M
    J Reprod Med; 2004 Oct; 49(10):837-48. PubMed ID: 15568410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HABITS (hormonal replacement therapy after breast cancer--is it safe?), a randomised comparison: trial stopped.
    Holmberg L; Anderson H;
    Lancet; 2004 Feb; 363(9407):453-5. PubMed ID: 14962527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription of hormone replacement therapy among cervical cancer patients with treatment-induced premature menopause.
    Suzuki Y; Huang Y; Ferris J; Kulkarni A; Hershman D; Wright JD
    Int J Gynecol Cancer; 2023 Jan; 33(1):26-34. PubMed ID: 36543392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality.
    O'Meara ES; Rossing MA; Daling JR; Elmore JG; Barlow WE; Weiss NS
    J Natl Cancer Inst; 2001 May; 93(10):754-62. PubMed ID: 11353785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iatrogenic Menopause After Treatment for Cervical Cancer.
    Moss EL; Taneja S; Munir F; Kent C; Robinson L; Potdar N; Sarhanis P; McDermott H
    Clin Oncol (R Coll Radiol); 2016 Dec; 28(12):766-775. PubMed ID: 27683104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of hormone replacement therapy on the outcome of iliac angioplasty and stenting.
    Timaran CH; Stevens SL; Grandas OH; Freeman MB; Goldman MH
    J Vasc Surg; 2001 Feb; 33(2 Suppl):S85-92. PubMed ID: 11174817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation.
    Corrao G; Zambon A; Conti V; Nicotra F; La Vecchia C; Fornari C; Cesana G; Contiero P; Tagliabue G; Nappi RE; Merlino L
    Ann Oncol; 2008 Jan; 19(1):150-5. PubMed ID: 17785762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy and menopause: a review of randomized, double-blind, placebo-controlled trials.
    Chang C; Lin CH
    Kaohsiung J Med Sci; 2003 Jun; 19(6):257-70. PubMed ID: 12873034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
    Lancet; 1997 Oct; 350(9084):1047-59. PubMed ID: 10213546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.